Drug Discovery Market CAGR Forecast Through 2030: Key Trends Shaping Industry Expansion
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Drug Discovery Market Set To Climb From $142.53 Billion In 2026 To $250.5 Billion By 2030
The drug discovery market size has experienced significant expansion in recent years. It will grow from $124.11 billion in 2025 to $142.54 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. This historical growth can be attributed to several factors, including an increase in chronic and infectious diseases, advancements in molecular biology techniques, heightened R&D spending by pharmaceutical companies, a rise in biotechnology collaborations, and the availability of research funding.
The drug discovery market is poised for significant expansion in the coming years. It is projected to reach a valuation of $250.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.1%. This expected growth during the forecast period is driven by the emergence of AI-driven drug discovery platforms, the expanding scope of personalized medicine, the integration of omics data into drug design, the increasing outsourcing in the biopharmaceutical sector, and the adoption of automation and robotics in laboratory environments. Prominent trends anticipated in this period include advancements in high-throughput screening, the development of targeted drugs, innovative personalized medicine strategies, the incorporation of pharmacogenomics, and the use of nanotechnology in drug discovery.
Get A Free Sample Report With In-Depth Market Insights:
Drug Discovery Market Growth Catalysts And Demand Drivers
The drug discovery market is anticipated to expand due to increasing healthcare spending. Globally, nations allocate a significant portion of their GDP to healthcare costs, encompassing hospital services, doctor and clinic visits, various professional services, dental treatments, additional health, residential, and personal care, home healthcare, nursing homes, continuing care retirement communities, prescription medicines, and other related expenditures. A substantial component of health expenditure is dedicated to drug discovery, crucial for disease treatment and life extension. The demand for novel drugs to address emerging diseases is growing. As an illustration, data from October 2024 from the Centers for Medicare and Medicaid Services, a US-based federal agency, revealed that national health expenditure increased by 4.1% to $4.5 trillion in 2022, equivalent to $13,493 per person. Furthermore, for the period 2023–32, the average national health expenditure growth (5.6%) is projected to surpass the average GDP growth (4.3%), leading to a rise in healthcare spending as a share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Consequently, the expansion of the drug discovery market is being propelled by increasing healthcare expenditures.
Drug Discovery Market Segment Outlook: Which Categories Are Growing Fastest?
The drug discovery market covered in this report is segmented –
1) By Drug Type: Small Molecule, Large Molecule
2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation
3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies
4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas
5) By End User: Pharmaceutical Companies, CROs, Other End-Users
Subsegments:
1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs
2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies
Drug Discovery Market Trends Shaping Long-Term Demand
Major companies operating in the drug discovery market are actively incorporating various innovative technologies, including artificial intelligence and imaging, to decrease the time necessary for drug development. Imaging technology specifically enables the non-invasive visualization, characterization, and quantification of biological activities occurring within organisms when exposed to medications. These techniques, which capitalize on the strengths of either specialized probes or the tissue itself, are essential for deepening the understanding of diseases and identifying new therapeutic options. For instance, in May 2023, Google Cloud launched two advanced AI-powered platforms, namely the Target and Lead Identification Suite and the Multiomics Suite, to expedite drug discovery and refine precision medicine. These tools are engineered to assist biotechnology and pharmaceutical companies in progressing their efforts in drug discovery and precision medicine. The Target and Lead Identification Suite aids in discerning the function of amino acids and proteins, whereas the Multiomics Suite accelerates the discovery and interpretation of genomic data, thereby contributing to the design of personalized treatments.
Drug Discovery Market Leading Companies And Competitive Benchmarking
Major companies operating in the drug discovery market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.
View The Full Drug Discovery Market Report:
Drug Discovery Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
